Pivot, X, Gligorov, J, Müller, V, Curigliano, G, Knoop, A, Verma, S, Jenkins, V, Scotto, N, Osborne, S, Fallowfield, L and PrefHer Study Group, (2014) Patients' preferences for subcutaneous trastuzumab versus conventional intravenous infusion for the adjuvant treatment of HER2-positive early breast cancer: final analysis of 488 patients in the international, randomized, two-cohort PrefHer study. Annals of Oncology, 25 (10). pp. 1979-1987. ISSN 0923-7534